<?xml version="1.0" encoding="UTF-8"?>
<contrib-group>
 <contrib contrib-type="author">
  <name>
   <surname>Leclerc</surname>
   <given-names>Vincent</given-names>
  </name>
  <xref ref-type="aff" rid="Aff1">1</xref>
  <xref ref-type="aff" rid="Aff2">2</xref>
  <xref ref-type="aff" rid="Aff3">3</xref>
 </contrib>
 <contrib contrib-type="author" corresp="yes">
  <name>
   <surname>Ducher</surname>
   <given-names>Michel</given-names>
  </name>
  <address>
   <phone>+33 4 72 16 71 44</phone>
   <email>michel.ducher@chu-lyon.fr</email>
  </address>
  <xref ref-type="aff" rid="Aff1">1</xref>
  <xref ref-type="aff" rid="Aff2">2</xref>
 </contrib>
 <contrib contrib-type="author">
  <name>
   <surname>Bleyzac</surname>
   <given-names>Nathalie</given-names>
  </name>
  <xref ref-type="aff" rid="Aff1">1</xref>
  <xref ref-type="aff" rid="Aff3">3</xref>
 </contrib>
 <aff id="Aff1">
  <label>1</label>
  <institution-wrap>
   <institution-id institution-id-type="ISNI">0000 0001 2150 7757</institution-id>
   <institution-id institution-id-type="GRID">grid.7849.2</institution-id>
   <institution>EMR 3738, Ciblage, Thérapeutique en Oncologie, Faculté de Médecine et de Maïeutique Lyon-Sud Charles Mérieux, Université Claude Bernard Lyon 1, </institution>
  </institution-wrap>165 chemin du Grand Revoyet-BP 12, 69921 Oullins Cedex, France 
 </aff>
 <aff id="Aff2">
  <label>2</label>
  <institution-wrap>
   <institution-id institution-id-type="ISNI">0000 0001 2163 3825</institution-id>
   <institution-id institution-id-type="GRID">grid.413852.9</institution-id>
   <institution>Hospices Civils de Lyon, Groupement Hospitalier Nord, Hôpital Pierre Garraud, Service pharmaceutique, </institution>
  </institution-wrap>136 rue du Commandant Charcot, 69005 Lyon, France 
 </aff>
 <aff id="Aff3">
  <label>3</label>Institute of Pediatric Hematology and Oncology, Place Professeur Joseph Renaut, 69008 Lyon, France 
 </aff>
</contrib-group>
